uu.seUppsala University Publications
Change search
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf
Predictability and performance of different non-linear mixed-effects models for HbA1c in patients with type 2 diabetes mellitus
Uppsala University, Disciplinary Domain of Medicine and Pharmacy, Faculty of Pharmacy, Department of Pharmaceutical Biosciences. Uppsala University, Disciplinary Domain of Science and Technology, Biology, Biology Education Centre.
2014 (English)Independent thesis Advanced level (degree of Master (Two Years)), 20 credits / 30 HE creditsStudent thesis
Abstract [en]

To accurately predict the outcome of a late phase study, pharmacometric models can help in drug development. Making informed decision on which models to use will also facilitate drug development. This can depend on the mechanism of action for the drug as well as stability and runtime factors.

This is an investigation of four published semi-mechanistic pharmacometric models to predict glycosylated red blood cells (HbA1c) in a late phase study of an anti-diabetic drug together with an assessment of their stability and power to detect drug effects. Mean plasma glucose (MPG), fasting plasma glucose (FPG) or FPG and fasting serum insulin (FSI) are used together with HbA1c as drivers for change in the models. We find that less complex models, with fewer differential equations, are quicker to run and more stable, and that MPG alone is superior to FPG or FPG and FSI to detect a drug effect. The findings are useful for drug development in the anti-diabetic area, and show that a less mechanistic model performs well under these conditions. 

Place, publisher, year, edition, pages
2014. , 35 p.
Series
UPTEC X, 14 002
Keyword [en]
Type 2 diabetes mellitus, semi-mechanistic models, HbA1c, glucose, insulin, NONMEM
National Category
Medical Biotechnology (with a focus on Cell Biology (including Stem Cell Biology), Molecular Biology, Microbiology, Biochemistry or Biopharmacy)
Identifiers
URN: urn:nbn:se:uu:diva-218843OAI: oai:DiVA.org:uu-218843DiVA: diva2:697610
Subject / course
Pharmaceutical Biosciences
Educational program
Molecular Biotechnology Engineering Programme
Presentation
2014-01-30, BMC C8:301, 14:00 (English)
Supervisors
Examiners
Available from: 2014-02-19 Created: 2014-02-18 Last updated: 2014-02-19Bibliographically approved

Open Access in DiVA

Pinkie Pie(2048 kB)581 downloads
File information
File name FULLTEXT01.pdfFile size 2048 kBChecksum SHA-512
714724810a0942dc7ace0c6af6319ed34f844454b3b3f91efe0bb64fbbfb9ad3ccb66ff7ddcb71e21fd80bddb6c0d94f85d91c785791daf46a6d59e70783ce7c
Type fulltextMimetype application/pdf

By organisation
Department of Pharmaceutical BiosciencesBiology Education Centre
Medical Biotechnology (with a focus on Cell Biology (including Stem Cell Biology), Molecular Biology, Microbiology, Biochemistry or Biopharmacy)

Search outside of DiVA

GoogleGoogle Scholar
Total: 581 downloads
The number of downloads is the sum of all downloads of full texts. It may include eg previous versions that are now no longer available

urn-nbn

Altmetric score

urn-nbn
Total: 604 hits
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf